
    
      The study is an intraindividual comparison of two methods. The number of subjects to be
      enrolled is 47. Patients will receive both treatments in a single visit: A first period of
      2.5 hours of illumination with Phos-Istos device followed by a continuous red light spectrum
      (between 7 and 10 minutes) with AktiliteÂ® after an appropriate incubation of MAL (methyl
      aminolevulinate). Patients will complete a pain assessment scale after receiving both
      treatments. 3 follow-up visits will be then scheduled
    
  